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T
he typical complexities of time-varying exposures, and by extension doses, generally require the
creation of summary exposure measures. When addressing the question of the appropriate form
of the summary measure of exposure, one is made aware of the strengths and limitations of
whichever exposure classifications are available. An essential consideration in the choice of a
summary measure of exposure is the time pattern of the effects of exposure. For some exposures and
outcomes the effects may be almost instantaneous (for example, acute toxicity), whereas in other
instances (for example, occupational cancer) it may take many years for the clinical effects of
exposure to occur and be observed. These temporal dynamics can lead to serious exposure
misclassification if ignored or misunderstood.
Taking account of biological variability when studying the effects of a chemical exposure is not a
new idea. Important contributions to this field were made by Roach in the 1960s and 1970s.1 2 Roach
showed how the rate of clearance of a chemical from the body could interact with the environmental
variability of the exposure to determine the toxic effects.2 3 These ideas were further developed into a
comprehensive biologically-based perspective on exposure sampling by Rappaport and colleagues.4–6
Smith and colleagues also raised these issues in the 1980s, particularly focusing on the limitations of
standard but overly simplified metrics like cumulative exposure.7 8
In this article we present concepts and methods that may be useful in the modelling of exposure–
risk relations in occupational epidemiology, and especially in the formulation and application of
quantitative summary measures of exposure or dose.9 We also present several examples from the
recent literature which illustrate these points.
FROM EXPOSURE TO DOSE: DEFINITIONSc
In almost every epidemiological study, exposure is a complex, time-varying quantity that must
be summarised before it can be used for exposure–response modelling. Thus, for worker i in a cohort
exposed for a fixed time interval to a potentially hazardous agent, the exposure history of that
worker from the beginning of exposure until the event of interest—the onset of some
physiological dysfunction, disease diagnosis or death—at time T can be summarised in a vector as
follows:
where xit is the exposure level for worker i in time periods t = 1,2,3...ni, and ni is the number of time
periods of exposure of the worker i prior to T. Most summary measures of exposure used in
epidemiology are summarised from the vector
For example, cumulative exposure (CE) can be derived from the exposure vector:
Exposures must enter a target organ and reach critical concentrations before injury can occur. For a
subject with an ongoing exposure, there is a profile of tissue concentrations (burdens) varying over
time in a way that is analogous to an exposure profile:
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where bit is the tissue burden for worker i in time periods
t = 1,2,3...ni, and ni is the number of time periods of exposure
of the subject i prior to T. The dose (D), analogous to
cumulative exposure, is therefore the time integral of the
burden vector:
Burden and dose are sometimes directly measurable using
biomarkers (for example, in vivo x ray fluorescence measure-
ment of cadmium in the kidney cortex), but in most studies this
is not feasible or economical.
SUMMARY MEASURES OF EXPOSURE
Cumulative exposure, the time integral of exposure intensity
(equation 2), is a commonly used summary measure in
occupational epidemiology. There are good reasons for this.
First, taking the example of an inhaled dust with the lung as
the target organ, cumulative exposure will be proportional to
dose in the target organ if one assumes that ventilation rates
are constant over time and similar among members of the
cohort, and that the fraction of the inhaled particles deposited
is also roughly constant over time and among subjects.7 Second,
target organ dose is often assumed to be directly proportional to
biological damage and disease risk. This appears to be a valid
assumption for a wide variety of disease mechanisms, although
we will discuss some exceptions later. Third, cumulative
exposure has been shown to correlate strongly with disease
risk in a wide variety of exposure–response associations.10
Other common summary measures of exposure include the
average, duration of exposure, and ‘‘peak’’ exposure (table 1).
Each of these will be appropriate for certain exposure–disease
processes, but not for others. To understand this fit of exposure
metric to disease process, it may be helpful to consider that the
‘‘black box’’ between exposure and disease involves two linked
dynamic processes: the exposure–dose relation, and the dose–
response relation, and that what is typically measured epidemio-
logically is the exposure–disease relation. Before selecting a
summary measure of exposure for an epidemiological study, it is
important to consider these two steps, and if possible, to have
explicit hypotheses about the nature of these two relations as a
means of minimising exposure misclassification.
To illustrate, consider a study of occupational exposure to
power frequency electromagnetic fields and risk of brain cancer.
Because of low cost microelectronics, it is relatively inexpensive
to conduct a fairly extensive exposure assessment for such a
study. A number of large scale studies have been conducted in
which personal measurements were obtained for cases and
controls, or on representative samples of workers in various
jobs.11 12 The ability to collect large numbers of measurements,
including continuous profiles of intensity over periods of time,
is not a common situation in occupational epidemiology, in
which it is often the case that relatively few measurements are
available, and each one entails substantial time and economic
costs for collection and analysis. Availability of large quantities
of exposure data highlights the challenge of selecting among
the most appropriate exposure metric from options that might
include cumulative exposure, duration, average intensity, peak
and various time-specific measures of each of these. Choosing
the most suitable metric is easiest when there is a strong
hypothesis about the biological mechanism by which the agent
(in this case electromagnetic fields) may act, although
exploratory exposure/response analyses involving alternative
metrics may be necessary in the absence of mechanistic
knowledge.13
If cumulative exposure is assumed to be proportional to risk,
then it follows that subjects with very different patterns of
exposure over time may have the same risk, as long as the
products of each subject’s average intensity and total duration
of exposure are the same. This assumption holds well for
cumulative damage processes—those in which each unit of
dose induces tissue or cell injury, and hence increases risk, by a
constant amount. For example, it is approximately true that
each ‘‘pack-year’’ of smoking (a cumulative exposure measure:
the number of packs of cigarettes smoked per day multiplied by
the number of years of smoking) causes a fixed amount of loss
in pulmonary function. Fibrotic diseases caused by environ-
mental toxins—for example, the pneumoconioses—seem to
follow this pattern. Most models used in cancer epidemiology
make the assumption of proportionality of risk with cumulative
exposure. Asbestos and lung cancer is one such example.
The choice of summary measure of exposure is essentially an
exercise in choosing weights: how much weight to attribute to
each component of the exposure profile, such that the summary
measure will be proportional to risk. There are two general
approaches to this choice of weights. First, one can choose
weights based on an explicit biological model. Alternatively,
one can employ an empirical weighting scheme, in which no
Table 1 Common summary measures of exposure
Summary measure of exposure Representative physiological processes
Name Description Description Example
Average exposure Arithmetic or geometric
mean of past exposures
Slowly or partially
reversible effects
Pulmonary irritants and FEV1
Cumulative exposure Product of intensity and
duration
Cumulative, irreversible
effects
Silica and silicosis
Duration of exposure Start of exposure to onset
of disease
As for cumulative
exposure
‘‘High’’ noise exposure and
hearing loss
Peak exposure Various measures of short
term, high exposure periods
Reversible, inflammatory
processes
Strain on lower back and back
pain
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explicit biological motivation exists for the chosen model form.
Instead, the epidemiological data are used to find the ‘‘best’’ or
‘‘most likely’’ weights, based on statistical fit properties. In
practice, a hybrid approach is often used in which model
selection involves choosing the best fit from among a set of
candidate models that have prior biological rationale.
An additional challenge that epidemiologists face when
choosing among alternative measures of exposure or dose is
that often measures that may have very different biological
significance are, in the study data, highly correlated. In such
cases, it is difficult or impossible to find evidence that one
metric is clearly better than another. This problem has often
been encountered when investigators attempt to study peak
exposures—jobs or individuals with high peak exposures often
have high mean or cumulative exposures as well.14–16
DOSIMETRIC MODELLING
Not all disease processes are characterised by a direct
proportionality between a simple summary measure (table 1)
and risk.17–19 When the degree of response of an individual to a
given unit of dose is variable over time, then a more complex
way to summarise the exposure history will be needed. In
particular, if the proportionality parameter which describes the
risk of disease per unit of dose (or exposure) is itself
determined by the individual’s history of exposure (and by
the history of response to that exposure), then the appropriate
exposure–risk model will be non-linear or dynamic. Suppose for
example that previous exposure to a toxic substance has
inhibited normal clearance or repair processes in a target tissue;
in this case later units of exposure would be predicted to be
more injurious than earlier ones.20 21 Alternatively, suppose that
a particular workplace exposure triggers a mutation which
modifies the toxicity of the agent. Such an acquired suscept-
ibility exemplifies another non-linear pathological process.22
Asthma is representative of another type of process: the
asthmatic exhibits an extreme sensitivity to an agent because
of an immunological response mechanism not present in that
individual before the development of asthma. If the asthma
was caused by a toxic exposure, then the incremental response
to a unit of exposure after asthma onset will be much greater
than in the same individual before onset.23 Finally, disease
processes in which effective repair mechanisms are stimulated
by injury would be expected to exhibit non-linear behaviour.
When disease risk is not thought to be proportional to dose,
then cumulative exposure may not be an appropriate summary
measure of exposure. In these situations, it may be preferable to
develop an alternative exposure measure which better reflects
what is known about the exposure–risk relation.8 17 For
example, the risk of a disease involving immune sensitisation
may be better reflected by an index which quantifies the
occurrence of short intense peaks of exposure than by average
or cumulative exposure measures. There is evidence that
beryllium sensitisation may have this behaviour.24 Measures
of exposure which are constructed using explicit hypotheses
about the exposure–dose and/or dose–risk relations are called
dose metrics, and the process of developing these measures is
called dosimetric modelling.
Dose metrics can be used in epidemiological analyses in the
same ways that summary measures of exposure are used. The
dosimetric model describes for each subject his/her exposure
profile, as modified by the hypothesised physiological processes
leading up to the time of disease onset. It could also include
factors which interact biologically with the exposure–response
process (effect modifiers) such as might occur if smoking
decreases the pulmonary clearance of a toxicant under study.
Dosimetric models nearly always involve some quantitative
parameters such as a clearance rate for the agent, or the rate of
repair of tissue damage, whose values must be specified before
the model can be used to estimate a dose metric. One can think
of these parameters simply as weights which, when applied to
the exposure data, yield quantities more closely associated with
outcome than the original exposure data themselves. But if
these parameters can be viewed as having some physiological
significance, then their quantitative estimation and interpreta-
tion are made easier. There are two approaches to parameter
quantification: one can either estimate them based on previous
epidemiological studies, experiments, studies with laboratory
animals, etc, or one can estimate them directly from the data
generated from the epidemiological study being conducted. If
the latter approach is used, the epidemiological dataset must be
fairly large, and the number of unknown parameters small and
not too strongly correlated with each other. For example, eight
or nine parameters could probably not be estimated reliably
from a few hundred subjects.
A dosimetric model of lead in bone and
neurobehavioural function
A recent example illustrating application of a dosimetric model
in occupational epidemiology was an investigation by Links and
colleagues.25 They estimated a measure of the ‘‘effective dose’’
of lead in the brain for an epidemiological study of 535 former
organolead workers. They first assumed that the area under the
time–tissue burden curve (dose, as defined above in equation 4,
but called ‘‘area under the curve’’, or AUC by Links et al) would
be proportional to measures of tissue damage, as reflected in
performance in a battery of 16 neurobehavioural tests. They
then estimated the AUC for each participant in the study and
examined its fit to the results of the neurobehavioural tests in
regression models. Using a one-compartment toxicokinetic
model,26 27 the investigators estimated individual doses based
on a single tibial bone lead concentration measure and dates of
employment for each participant
The dosimetric modelling had the following main steps. For
each worker, a measure of bone lead concentration made years
after the cessation of exposure was available. These measure-
ments were made non-invasively by measuring lead in the tibia
with x ray fluorescence. A blood lead measurement was also
taken at the same time. The clearance half time of lead in bone
was estimated to be 27 years, based on previous studies, and
because exposure had ceased years before the bone lead
measurements, it was possible to back-extrapolate from the
current tibial lead concentration to a peak tibial lead
concentration at the date of termination of exposure.
The relative performance of the four different metrics in
predicting neurobehavioural function was investigated. The
four metrics were: current blood lead, current tibial lead, peak
tibial lead and tibial dose, or AUC. The workers were tested on
the neurobehavioural test battery at two time points, four years
apart, and the change in performance over four years was the
outcome variable. The four different personal lead measures
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were separately regressed against each of the 16 different
neurobehavioural tests, to evaluate the relative performance of
each. The AUC appeared to be more strongly associated with
the neurobehavioural test results than the other three measures
(table 2). Comparing the current exposure metrics—current
blood and tibial lead concentrations—to the metrics which
reflect the history of exposure—peak tibial lead concentration
and AUC—there was a tendency for stronger associations
(larger negative regression coefficients) with the latter (table 2).
The comparative fits of the alternative metrics provide
insights into the temporal dynamics of lead’s effects on
neurological function. If a measure of recent or current
exposure (blood lead concentration) were more strongly
associated with the outcome measures, this would argue for
an acute reversible damage process, and a short residence time
of lead in the brain. This might suggest that the neurobeha-
vioural effects were largely due to recent releases of lead from
bones, as the clearance half time of lead in blood is about
30 days, and the cohort members had not been exposed for
years. The association with AUC in contrast reflects the
dynamics of uptake, clearance and progressive damage from
the accumulation of irreversible effects as well as continuing
decrements from ongoing releases of lead from bone. Personal
estimates of exposure intensity for each participant during his
working life would have been useful, but their absence did not
prevent some important insights into the biological basis for the
neurobehavioural deficits observed among these former lead
workers.
A dosimetric model of ergonomic stressors and low back
pain
Another good example of the application of a simple dosimetric
model is provided by a study by Krajcarski and Wells28 29 on risk
of lower back pain in automobile assembly workers. The
investigators gathered a large amount of information on
ergonomic stressors and symptoms among a cohort of workers
engaged in repetitive tasks characterised by a short work cycle
on a production line.30 31 A detailed analysis of each task
performed in each job was conducted to estimate ergonomic
exposures relevant to risk of lower back injury. These included
compression and shear forces at several different points along
the spine, as well as peak and static moments (N?m).
Estimating these exposures was a very time- and labour-
intensive process for the investigators, involving video taping
each task, and then extracting from the video images the input
data for a two-dimensional biomechanical model which then
produced the estimated forces. For the substudy described here,
the data were analysed for a sample of 34 cases of new onset
lower back pain and 34 controls from the same plant. A single
exposure, the L4/L5 extensor moment, was chosen because of
previous studies suggesting that it may be an important
predictor of back pain. These exposure data were used to
produce two summary measures of exposure for each of the 68
participants: the integrated moment (N?m?s/shift) across a
work shift (a measure of cumulative exposure), and the peak
moment (the highest estimated L4/L5 extensor moment during
the work shift).
Krajcarski and Wells also calculated a dose metric from these
exposure data using a single compartment model. They
hypothesised that the association between spine forces and
back pain would be more accurately estimated if the time-
varying patterns of force and rest periods over the work shift
were properly integrated. The metric they estimated had
arbitrary units, but was hypothesised to be proportional to
the degree of injury in the lower back caused by the forces
exerted on the spine during work. Their model produced a dose
metric which was a weighted function of the exposure data,
with a single unknown parameter. The value of this parameter,
which can be thought of as a recovery half-time, could be
chosen a priori on the basis of experimental studies on the
injury and repair processes of the soft tissues of the lower back.
For example, a variety of different physiological processes
associated with muscle fatigue have recovery times of about
5000 seconds (1.4 h) including intramuscular pH changes and
lactic acid removal. The automobile assembly work typical of
this study population produced patterns of exposure—the L4/L5
extensor moment—characterised by short bursts of high force
separated by periods of rest. In contrast, a dose metric assuming
Table 2 Associations of neurobehavioural tests with various lead exposure/dose metrics.
From a cross-sectional study of 535 former lead workers (adapted from Links et al25)
Neurobehavioural measure*
Current PbB Current PbT Peak PbT AUC dose metric
b` p Value1 b p Value b p Value b p Value
Wechsler block design 0.161 0.23 20.058 0.72 20.223 0.18 20.213 0.22
Wechsler symbol digit 20.187 0.14 20.133 0.32 20.038 0.79 0.058 0.68
Symbol digit 20.012 0.91 20.099 0.32 20.206 0.05 20.225 0.04
Serial digit learning 20.160 0.23 20.020 0.90 20.104 0.52 20.149 0.37
Rey figure copy 20.001 0.99 20.030 0.74 20.138 0.14 20.170 0.08
Rey figure recall 20.174 0.05 20.077 0.39 20.174 0.07 20.196 0.04
Rey auditory learning, immediate
recall
0.049 0.77 20.255 0.15 20.571 ,0.001 20.671 ,0.001
Rey auditory learning, delayed recall 20.055 0.32 20.128 0.02 20.149 0.01 20.134 0.02
*Selection from a battery of 16 tests. All tests scored so that a worsening of performance with increasing exposure is
indicated by a negative sign.
Dose metrics: current PbB, current blood lead concentration, at time of testing; current PbT, current tibial lead
concentration, at time of testing; peak PbT, highest estimated tibial lead concentration, back-extrapolated using a one-
compartment model and an average clearance half time of 27 years; AUC dose metric, area under the time-
concentration curve for tibial lead.
`Regression coefficient, adjusted for age, education and baseline score, and standardised so that all b represent change
in score per standard deviation change in exposure/dose metric.
1p Value testing H0: b= 0. Large coefficients relative to their standard errors indicated in bold italics.
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a recovery time of 5000 seconds and generated from a typical
exposure profile over a work shift shows a steady accumulation
of damage, with little or no repair over rest breaks. The
investigators evaluated a wide range of different values of the
recovery time parameter t, rather than choosing one a priori. A
logistic regression model was used to estimate the strength of
the association between the dose metric and lower back pain.
This exercise was then conducted twice; once for the integrated
metric for the entire work shift and once for the highest
attained value of the metric—analogous to the peak moment or
exposure.
The fit of the dose metrics in the logistic regression models
for back pain can be compared to similar models using the
exposure measures, integrated and peak moment (table 3).
When a short recovery time (2 seconds) was chosen, peak dose
metric showed a stronger association (higher odds ratio) with
risk than the peak exposure data. The dose metric with a long
recovery time (5000 seconds) was only slightly more strongly
associated with risk than the integrated moment data (that is,
cumulative exposure), suggesting that its performance was not
much different from cumulative exposure.
The model also allowed an investigation of alternative
assumptions about the recovery time. This can be thought of
as a kind of sensitivity analysis, and also as a way of using
epidemiological data to provide information about a biological
process, the recovery time following strain. For values of the
recovery parameter t, ranging from 1 to 100 000 seconds, the
dose metric was calculated for each of the 68 participants, and
then each resulting set of dosimetric data was fit to the case
control data to calculate an odds ratio (fig 1). These odds ratios
were then plotted against the varying values of t to yield a
continuous trend. The two peaks in this figure suggest that two
very different physiologic processes are at work—one quite
short (about 2 seconds) and the other on a much longer time
scale (about 1000 seconds). Such information may be useful for
improving understanding of pathophysiological mechanisms
underlying repetitive strain injuries.
The preceding two examples illustrate models in which it was
necessarily assumed that critical model parameters, such as
clearance and physiological recovery times, were constant
among all members of the population. It would be desirable
to be able to relax this assumption, when data permit. The
following example illustrates the use of data on individual risk
modifiers to estimate dose metrics that will vary among cohort
members with the same exposure experience.
A dosimetric model of dioxin exposure and lung cancer
A cohort study conducted by Fingerhut and colleagues found
increased all-cause cancer as well as lung cancer mortality
among workers at 12 US chemical plants where dioxin
exposure occurred.32 Salvan and colleagues used serum TCDD
(2, 3, 7, 8-tetradichlorodibenzo-p-dioxin) data collected at a
single point in time on a subset of these workers, combined
with occupational history data, to estimate a lifetime dioxin
dose (part per trillion-years) for the members of this cohort.33 34
It was hypothesised that body fat would be inversely propor-
tional to bodily clearance of dioxin. The model had the form of
a single compartment pharmacokinetic model assuming linear
kinetics. Individual body mass index data were available for
about 80% of the cohort, and were used to estimate per cent
body fat and its rate of change over time among cohort
members. The clearance parameter of the one compartment
model was allowed to vary among individuals and within
individuals over time, determined by time-dependent indivi-
dual per cent body fat estimates. The investigators used the
resulting individual serum TCDD dose estimates in a cohort
mortality analysis to estimate the cancer rate ratios comparing
those with doses based on only ‘‘background’’ dioxin exposure
(assumed to be 7 parts per trillion-years) to those with doses up
to 1000 times this level. The results suggest a strong association
between dioxin dose and lung cancer, and because this analysis
used serum TCDD doses and not simply the exposure data, the
results may be more readily generalised to other populations for
which serum doses were either measured directly, or estimated
with a dosimetric model.
CHOOSING THE BEST EXPOSURE/DOSE METRIC
Epidemiological studies can be expensive and time-consuming,
especially when a careful exposure assessment has been
performed. When the time comes to analyse the data, it is
hard to justify selecting just one measure of exposure or dose—
in practice, several different measures are generally tested. How
then, are we to choose among the various associations that
result from this repeated analysis? What are the criteria for
choosing the ‘‘best’’ measure of exposure?
First, the better indices will usually yield better statistical fits
to the epidemiological data.35 It is tempting to think that the
better index will yield a stronger association with outcome (as
in greater slope or higher relative risk), but this method has
been shown to potentially lead to bias.36 There is also the
problem that different indices often have different scales, such
that they cannot be directly compared. Goodness of fit will
often be evaluated with a likelihood statistic, such as the 22-
log likelihood, or the deviance. In linear models, an overall F
statistic is preferable to the R2 as a measure of fit, because the
latter is quite sensitive to changes in extreme values. An
additional problem is that if the exposure estimates derived
from the various plausible models are strongly correlated with
each other and/or are measured with significant misclassifica-
tion, then an ‘‘inferior’’ model may show a better statistical fit
than a ‘‘superior’’ model in a particular dataset. Thus, the
decision as to which model is most appropriate to use should
not be based solely on statistical performance.
Table 3 Comparison of low back pain risk estimates (odds
ratios) for different exposure/dose metrics from a case–
control study among automobile assembly workers
Peak vs
cumulative
measure Exposure/dose metric Odds ratio* 95% CI
Peak Exposure (% MVE) 1.5 (1.0 to 2.6)
Dose metric (t= 2 s) 2.2 (1.1 to 4.7)
Cumulative Exposure (N?m?s/shift) 1.9 (1.0 to 3.9)
Dose metric (t= 5000 s) 1.9 (1.1 to 3.8)
*Odds ratios compare risk for the 75th versus the 25th percentiles of the
distribution of the exposure/dose measure.
Peak exposure expressed as percentage of the maximum voluntary
extensor moment (gender specific).
Exposure is extensor moment at L4/L5. Dose metric from a first order system
with recovery time constant (?) of 2 or 5000 seconds (adapted from
Krajcarski et al29).
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In particular, there may be reasons to choose one exposure
index or dose metric over another, even if it is not clearly
superior in statistical performance. Ease of interpretation and
comprehension may be additional considerations. Also, mea-
sures which are more easily generalisable across exposure
settings are advantageous, if the objective is to make predic-
tions about risk. A dose metric may be preferable to an
exposure index if there are several routes of exposure, and one
wants to estimate risk via all routes combined. Also, if one
wants to be able to use the results to make predictions about
risks resulting from quite varied exposures (different time
patterns or routes), then a dose metric may be desirable.
A dosimetric model may provide an explicit method for
considering interactions among different exposures. For exam-
ple, Smith constructed a dosimetric model for silica and lung
fibrosis which explicitly incorporated the effect of smoking on
particle clearance from the airways.37 This may be preferable to
the standard approach of including smoking as an independent
covariate in the epidemiological model.
CONCLUSIONS
Dosimetric modelling may be useful to improve the sensitivity of
epidemiological models. However, it will never make up for
deficiencies in the measurement of exposure; bad exposure data
cannot be improved by estimating dose. Further, one must be
careful that errors in exposure estimation are not hidden by
feeding them into a dosimetric model, removing the risk analysis
a further step from the raw exposure data. That said, there are
several important motivations for dosimetric modelling. First, in
some situations it may improve study validity and precision by
weighting exposure data in a way that improves the fit of
epidemiological models. This is especially likely to occur when
studying non-linear exposure-risk relations, and may allow
greater sensitivity in the detection of new, previously unidentified
hazards. Epidemiologists can study exposures which confer fairly
large risks without the need for dose modelling; even if the use of
simple exposure measures introduces substantial misclassifica-
tion, the risk may still be detectable. A second, related motivation
is that dosimetric modelling may allow epidemiologists to
investigate new mechanistic hypotheses formally in ways that
are not possible with simple measures of exposure. Also,
dosimetric models make it easier to extrapolate results, particu-
larly when multiple routes of exposure are involved. Despite these
potential advantages, dosimetric modelling should not be a
substitute for conventional exposure–response analysis. It may be
a logical next step, after the exposure data have been used to their
fullest to quantify exposure–risk associations. At that point,
dosimetric modelling may be useful for all of these reasons.
A serious deterrent to dosimetric modelling is the need for
additional assumptions about the structure of the model, and
the values of its parameters. It is important to remember,
however, that if one chooses a simple summary measure of
exposure, one is substituting implicit assumptions for explicit
ones (about the proportionality between the exposure and dose,
for example), and the same misclassification will result in
either case if the assumptions are incorrect.
Dosimetric modelling has great potential for risk identifica-
tion and dose–response characterisation. Further applications
in occupational epidemiology should be encouraged where
adequate exposure data are available.
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